Literature DB >> 2521488

Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia.

E Shinar1, E A Rachmilewitz, S E Lux.   

Abstract

Thalassemic red cells show irregular morphology and maldistribution of glycoproteins and sialic acids. These changes are compatible with damage to the red cell membrane skeleton. To test this possibility, we systematically studied the interconnections of skeletal proteins in patients with a form of alpha thalassemia (HbH disease), in patients with beta thalassemia intermedia, and in normal individuals. Alpha- and beta-thalassemic spectrin functions normally in spectrin self-association, binding to normal inside-out vesicles (IOVs), and binding to actin in the presence and absence of normal protein 4.1. Binding of normal spectrin to beta: thalassemic IOVs is normal but alpha-thalassemic IOVs are defective and bind only half the normal amount of spectrin (66 +/- 5 vs. 120 +/- 16 micrograms spectrin dimer/mg IOV protein, respectively). A different defect is detected in beta thalassemia, in which protein 4.1 shows markedly reduced ability (48 +/- 7% of normal) to enhance the binding of normal spectrin to actin and a decreased ability to bind normal spectrin in a binary interaction, compared with normal protein 4.1 (24 +/- 1 and 43 +/- 1 micrograms protein 4.1/mg spectrin, respectively). As no quantitative deficiency of beta-thalassemic protein 4.1 is detected, we assume an acquired lesion is present, which affects about half of the protein 4.1 molecules. These findings indicate that specific, localized, yet different defects exist in the skeletal proteins of alpha- and beta-thalassemic red cells. The different molecular lesions imply that the mechanism of hemolysis and probably the interaction of unpaired globin chains with the membrane differs in the two diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521488      PMCID: PMC303695          DOI: 10.1172/JCI113898

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Membrane protein lesions in erythrocytes with Heinz bodies.

Authors:  O S Platt; J F Falcone
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Ultrastructural studies of the interaction of spectrin with phosphatidylserine liposomes.

Authors:  A M Cohen; S C Liu; L H Derick; J Palek
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

4.  The effect of mild diamide oxidation on the structure and function of human erythrocyte spectrin.

Authors:  P S Becker; C M Cohen; S E Lux
Journal:  J Biol Chem       Date:  1986-04-05       Impact factor: 5.157

5.  Protein 4.1 in sickle erythrocytes. Evidence for oxidative damage.

Authors:  R S Schwartz; A C Rybicki; R H Heath; B H Lubin
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

6.  The interaction of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane.

Authors:  J A Walder; R Chatterjee; T L Steck; P S Low; G F Musso; E T Kaiser; P H Rogers; A Arnone
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

7.  Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia.

Authors:  E Shinar; O Shalev; E A Rachmilewitz; S L Schrier
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

8.  Biochemical characterization of complex formation by human erythrocyte spectrin, protein 4.1, and actin.

Authors:  C M Cohen; S F Foley
Journal:  Biochemistry       Date:  1984-12-04       Impact factor: 3.162

9.  Regulation of the association of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinositide.

Authors:  R A Anderson; V T Marchesi
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

10.  Restoration of normal membrane stability to unstable protein 4.1-deficient erythrocyte membranes by incorporation of purified protein 4.1.

Authors:  Y Takakuwa; G Tchernia; M Rossi; M Benabadji; N Mohandas
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

View more
  16 in total

1.  Insights into hemoglobin assembly through in vivo mutagenesis of α-hemoglobin stabilizing protein.

Authors:  Eugene Khandros; Todd L Mollan; Xiang Yu; Xiaomei Wang; Yu Yao; Janine D'Souza; David A Gell; John S Olson; Mitchell J Weiss
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

2.  Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes.

Authors:  M D Scott; J J van den Berg; T Repka; P Rouyer-Fessard; R P Hebbel; Y Beuzard; B H Lubin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.

Authors:  P V Browne; O Shalev; F A Kuypers; C Brugnara; A Solovey; N Mohandas; S L Schrier; R P Hebbel
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Thromboelastometry profile in children with beta-thalassemia.

Authors:  Ayşe B Turhan; Özcan Bör; O Meltem Akay; Necat A Akgün
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

Review 5.  Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia.

Authors:  Viktoria Kuhn; Lukas Diederich; T C Stevenson Keller; Christian M Kramer; Wiebke Lückstädt; Christina Panknin; Tatsiana Suvorava; Brant E Isakson; Malte Kelm; Miriam M Cortese-Krott
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

6.  The regulation of erythropoiesis by selenium in mice.

Authors:  Naveen Kaushal; Shailaja Hegde; Jeanne Lumadue; Robert F Paulson; K Sandeep Prabhu
Journal:  Antioxid Redox Signal       Date:  2011-02-25       Impact factor: 8.401

Review 7.  What can we learn from ineffective erythropoiesis in thalassemia?

Authors:  Paraskevi Rea Oikonomidou; Stefano Rivella
Journal:  Blood Rev       Date:  2017-10-03       Impact factor: 8.250

8.  An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis.

Authors:  Xiang Yu; Yi Kong; Louis C Dore; Osheiza Abdulmalik; Anne M Katein; Suiping Zhou; John K Choi; David Gell; Joel P Mackay; Andrew J Gow; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia.

Authors:  Yi Kong; Suiping Zhou; Anthony J Kihm; Anne M Katein; Xiang Yu; David A Gell; Joel P Mackay; Kazuhiko Adachi; Linda Foster-Brown; Calvert S Louden; Andrew J Gow; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

10.  Coagulopathy in Beta-thalassemia: current understanding and future perspectives.

Authors:  M Domenica Cappellini; Khaled M Musallam; Alessia Marcon; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.